Your Technical Roadmap to ICH Q3E Compliance
ICH Q3E harmonises extractables and leachables requirements globally — a single, science-based framework across all major regulatory markets. Proactive alignment now prevents costly remediation post-2027.
The public consultation for the ICH Q3E draft guideline is complete. As the industry moves toward final adoption, pharmaceutical manufacturers must define and implement a robust, risk-based Impurity Control Strategy.
What this means for you: ICH Q3E harmonises extractables and leachables requirements globally — a single, science-based framework across all major regulatory markets. Proactive alignment now prevents costly remediation post-2027.
Why Early Adoption is a Competitive Strategy
Waiting for final publication risks significant operational overloads. Early engagement enables your teams to act — not react.
Identify Critical Gaps
Detect vulnerabilities in early development and lifecycle management stages before they impact timelines or require costly rework.
Build a Science-Based Roadmap
Establish a compliance strategy consistent with ICH principles — grounded in data, defensible at inspection, and scalable across your portfolio.
Align Stakeholders Early
Create a unified compliance culture across R&D, MS&T, Quality, and Regulatory — before the pressure of a hard deadline forces reactive decisions.
A Phased Approach to E&L Management
Structured support across three phases — from proactive readiness through to long-term lifecycle compliance.
The ‘Readiness Roadmap’
- Data Mapping & Architecture: Structuring E&L data for long-term use.
- Impact Assessments: Current compliance status and gap identification against ICH Q3E.
- Awareness Training: SME-led sessions to align risk-based decision-making.
- Regulatory Intelligence: Continuous monitoring of the evolving landscape.
Full Programme of Support Services
- Comprehensive support post the July 2027 adoption date.
- Rapid-response technical and regulatory assistance.
- Inspection readiness reviews and gap remediation.
Continuing Compliance Support
- Ongoing ICH Q3E implementation support for your programme.
- Lifecycle management for evolving product portfolios.
- Strategic regulatory updates and advisory services.
Start Bridging Your E&L Compliance Gap
Build your adoption roadmap before the 2027 deadline.
Understand the full scope of PLG’s ICH Q3E support services and our phased delivery model.
Use the form below to discuss how we can start supporting your programme today. We’ll get back to you within one business day.
Tell us about your portfolio and we’ll get back to you within one business day.